These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 16357154)
1. Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Riggi N; Cironi L; Provero P; Suvà ML; Kaloulis K; Garcia-Echeverria C; Hoffmann F; Trumpp A; Stamenkovic I Cancer Res; 2005 Dec; 65(24):11459-68. PubMed ID: 16357154 [TBL] [Abstract][Full Text] [Related]
2. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells. Girnita L; Girnita A; Wang M; Meis-Kindblom JM; Kindblom LG; Larsson O Oncogene; 2000 Aug; 19(37):4298-301. PubMed ID: 10980604 [TBL] [Abstract][Full Text] [Related]
3. The Biology of Ewing sarcoma. Riggi N; Stamenkovic I Cancer Lett; 2007 Aug; 254(1):1-10. PubMed ID: 17250957 [TBL] [Abstract][Full Text] [Related]
4. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors. Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038 [TBL] [Abstract][Full Text] [Related]
5. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma. Riggi N; Cironi L; Provero P; Suvà ML; Stehle JC; Baumer K; Guillou L; Stamenkovic I Cancer Res; 2006 Jul; 66(14):7016-23. PubMed ID: 16849546 [TBL] [Abstract][Full Text] [Related]
6. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors. Hu-Lieskovan S; Zhang J; Wu L; Shimada H; Schofield DE; Triche TJ Cancer Res; 2005 Jun; 65(11):4633-44. PubMed ID: 15930281 [TBL] [Abstract][Full Text] [Related]
7. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro. Chansky HA; Barahmand-Pour F; Mei Q; Kahn-Farooqi W; Zielinska-Kwiatkowska A; Blackburn M; Chansky K; Conrad EU; Bruckner JD; Greenlee TK; Yang L J Orthop Res; 2004 Jul; 22(4):910-7. PubMed ID: 15183454 [TBL] [Abstract][Full Text] [Related]
8. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance. Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047 [TBL] [Abstract][Full Text] [Related]
9. Advances in Ewing's sarcoma research: where are we now and what lies ahead? Ordóñez JL; Osuna D; Herrero D; de Alava E; Madoz-Gúrpide J Cancer Res; 2009 Sep; 69(18):7140-50. PubMed ID: 19738075 [TBL] [Abstract][Full Text] [Related]
10. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells. Wang M; Xie Y; Girnita L; Nilsson G; Dricu A; Wejde J; Larsson O Exp Cell Res; 1999 Jan; 246(1):38-46. PubMed ID: 9882513 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the transcriptional function of p53 by EWS-Fli1 chimeric protein in Ewing Family Tumors. Li Y; Tanaka K; Fan X; Nakatani F; Li X; Nakamura T; Takasaki M; Yamamoto S; Iwamoto Y Cancer Lett; 2010 Aug; 294(1):57-65. PubMed ID: 20153576 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias. Yi H; Fujimura Y; Ouchida M; Prasad DD; Rao VN; Reddy ES Oncogene; 1997 Mar; 14(11):1259-68. PubMed ID: 9178886 [TBL] [Abstract][Full Text] [Related]
13. EWS/ETS proteins promote expression and regulate function of the homeodomain transcription factor BRN3A. Gascoyne DM; Dunne J; Behjati S; Sebire NJ; Anderson J; Latchman DS Oncogene; 2010 May; 29(21):3134-45. PubMed ID: 20348952 [TBL] [Abstract][Full Text] [Related]
14. EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells. Riggi N; Suvà ML; Suvà D; Cironi L; Provero P; Tercier S; Joseph JM; Stehle JC; Baumer K; Kindler V; Stamenkovic I Cancer Res; 2008 Apr; 68(7):2176-85. PubMed ID: 18381423 [TBL] [Abstract][Full Text] [Related]
15. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes. Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222 [TBL] [Abstract][Full Text] [Related]
16. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma. Lin PP; Brody RI; Hamelin AC; Bradner JE; Healey JH; Ladanyi M Cancer Res; 1999 Apr; 59(7):1428-32. PubMed ID: 10197607 [TBL] [Abstract][Full Text] [Related]
17. Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids. Athanasiou M; LeGallic L; Watson DK; Blair DG; Mavrothalassitis G Cancer Gene Ther; 2000 Aug; 7(8):1188-95. PubMed ID: 10975680 [TBL] [Abstract][Full Text] [Related]
18. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells. García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936 [TBL] [Abstract][Full Text] [Related]
19. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Sorensen PH; Lessnick SL; Lopez-Terrada D; Liu XF; Triche TJ; Denny CT Nat Genet; 1994 Feb; 6(2):146-51. PubMed ID: 8162068 [TBL] [Abstract][Full Text] [Related]
20. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. Lessnick SL; Braun BS; Denny CT; May WA Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]